RK

Ritu Kumari

Active Director Director DIN 07378327
DIN 07378327 First appointment Jan 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2016
Shareholding value •••• Premium profile

About Ritu Kumari

Data last updated:

Ritu Kumari is a Director at Andwin Pharma Private Limited (since 2016). The company operates in Pharma. Andwin Pharma Private Limited reported revenue of ₹2.91 Cr (FY 2025).

DIN 07378327
Primary Designation Director
Industry Pharma
First Appointment 22 Jan 2016
Oldest Company Age 10 yrs
Largest company Andwin Pharma Private Limited · ₹2.91 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Andwin Pharma Private Limited U51909KA2016PTC085491
Director22 Jan 20162016₹2.91 Cr (FY 2025)Active

Board colleagues of Ritu Kumari

NameDINCompanyDesignation
Rana Amrendra Kumar Deepak02575084Andwin Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Andwin Pharma Private Limited
Premium access

Shareholding and investment profile for Ritu Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Kumari

Ritu Kumari currently holds 1 directorship: Andwin Pharma Private Limited (Director, since 22 Jan 2016, revenue ₹2.91 Cr (FY 2025)).

Ritu Kumari was first appointed on 22 Jan 2016 as Director at Andwin Pharma Private Limited.

The current boards of Ritu Kumari's companies include Rana Amrendra Kumar Deepak (Andwin Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available